IL10 and acute pancreatitis: Interleukin (IL)-10, a potent anti-inflammatory cytokine, was reported to be released during the course of experimental acute pancreatitis and was shown to limit the severity of this disease by downregulating the release of proinflammatory mediators [6], [7].